Global Standard Lancets Market Insights, Forecast to 2028

  • Report ID:195058
  • Industry Name: Medical Devices & Consumables
  • Publishing Date: Apr-22
  • No. of Pages: 126
                              
Standard Lancets market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Standard Lancets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Needle Blade Segment by Application Hospitals and Clinics Homecare Settings Others By Company Roche Lifescan BD Bayer Abbott B. Braun ARKRAY Terumo I-SENS Nipro Omron Infopia AgaMatrix Smiths Medical Sarstedt SANNUO Yicheng Yuwell Greiner Bio One Edan Narang Medical By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE
                        
1 Study Coverage 1.1 Standard Lancets Product Introduction 1.2 Market by Type 1.2.1 Global Standard Lancets Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Needle 1.2.3 Blade 1.3 Market by Application 1.3.1 Global Standard Lancets Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals and Clinics 1.3.3 Homecare Settings 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Standard Lancets Sales Estimates and Forecasts 2017-2028 2.2 Global Standard Lancets Revenue Estimates and Forecasts 2017-2028 2.3 Global Standard Lancets Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Standard Lancets Sales by Region 2.4.1 Global Standard Lancets Sales by Region (2017-2022) 2.4.2 Global Sales Standard Lancets by Region (2023-2028) 2.5 Global Standard Lancets Revenue by Region 2.5.1 Global Standard Lancets Revenue by Region (2017-2022) 2.5.2 Global Standard Lancets Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Standard Lancets Sales by Manufacturers 3.1.1 Global Top Standard Lancets Manufacturers by Sales (2017-2022) 3.1.2 Global Standard Lancets Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Standard Lancets in 2021 3.2 Global Standard Lancets Revenue by Manufacturers 3.2.1 Global Standard Lancets Revenue by Manufacturers (2017-2022) 3.2.2 Global Standard Lancets Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Standard Lancets Revenue in 2021 3.3 Global Standard Lancets Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Standard Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Standard Lancets Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Standard Lancets Sales by Type 4.1.1 Global Standard Lancets Historical Sales by Type (2017-2022) 4.1.2 Global Standard Lancets Forecasted Sales by Type (2023-2028) 4.1.3 Global Standard Lancets Sales Market Share by Type (2017-2028) 4.2 Global Standard Lancets Revenue by Type 4.2.1 Global Standard Lancets Historical Revenue by Type (2017-2022) 4.2.2 Global Standard Lancets Forecasted Revenue by Type (2023-2028) 4.2.3 Global Standard Lancets Revenue Market Share by Type (2017-2028) 4.3 Global Standard Lancets Price by Type 4.3.1 Global Standard Lancets Price by Type (2017-2022) 4.3.2 Global Standard Lancets Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Standard Lancets Sales by Application 5.1.1 Global Standard Lancets Historical Sales by Application (2017-2022) 5.1.2 Global Standard Lancets Forecasted Sales by Application (2023-2028) 5.1.3 Global Standard Lancets Sales Market Share by Application (2017-2028) 5.2 Global Standard Lancets Revenue by Application 5.2.1 Global Standard Lancets Historical Revenue by Application (2017-2022) 5.2.2 Global Standard Lancets Forecasted Revenue by Application (2023-2028) 5.2.3 Global Standard Lancets Revenue Market Share by Application (2017-2028) 5.3 Global Standard Lancets Price by Application 5.3.1 Global Standard Lancets Price by Application (2017-2022) 5.3.2 Global Standard Lancets Price Forecast by Application (2023-2028) 6 North America 6.1 North America Standard Lancets Market Size by Type 6.1.1 North America Standard Lancets Sales by Type (2017-2028) 6.1.2 North America Standard Lancets Revenue by Type (2017-2028) 6.2 North America Standard Lancets Market Size by Application 6.2.1 North America Standard Lancets Sales by Application (2017-2028) 6.2.2 North America Standard Lancets Revenue by Application (2017-2028) 6.3 North America Standard Lancets Market Size by Country 6.3.1 North America Standard Lancets Sales by Country (2017-2028) 6.3.2 North America Standard Lancets Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Standard Lancets Market Size by Type 7.1.1 Europe Standard Lancets Sales by Type (2017-2028) 7.1.2 Europe Standard Lancets Revenue by Type (2017-2028) 7.2 Europe Standard Lancets Market Size by Application 7.2.1 Europe Standard Lancets Sales by Application (2017-2028) 7.2.2 Europe Standard Lancets Revenue by Application (2017-2028) 7.3 Europe Standard Lancets Market Size by Country 7.3.1 Europe Standard Lancets Sales by Country (2017-2028) 7.3.2 Europe Standard Lancets Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Standard Lancets Market Size by Type 8.1.1 Asia Pacific Standard Lancets Sales by Type (2017-2028) 8.1.2 Asia Pacific Standard Lancets Revenue by Type (2017-2028) 8.2 Asia Pacific Standard Lancets Market Size by Application 8.2.1 Asia Pacific Standard Lancets Sales by Application (2017-2028) 8.2.2 Asia Pacific Standard Lancets Revenue by Application (2017-2028) 8.3 Asia Pacific Standard Lancets Market Size by Region 8.3.1 Asia Pacific Standard Lancets Sales by Region (2017-2028) 8.3.2 Asia Pacific Standard Lancets Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Standard Lancets Market Size by Type 9.1.1 Latin America Standard Lancets Sales by Type (2017-2028) 9.1.2 Latin America Standard Lancets Revenue by Type (2017-2028) 9.2 Latin America Standard Lancets Market Size by Application 9.2.1 Latin America Standard Lancets Sales by Application (2017-2028) 9.2.2 Latin America Standard Lancets Revenue by Application (2017-2028) 9.3 Latin America Standard Lancets Market Size by Country 9.3.1 Latin America Standard Lancets Sales by Country (2017-2028) 9.3.2 Latin America Standard Lancets Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Standard Lancets Market Size by Type 10.1.1 Middle East and Africa Standard Lancets Sales by Type (2017-2028) 10.1.2 Middle East and Africa Standard Lancets Revenue by Type (2017-2028) 10.2 Middle East and Africa Standard Lancets Market Size by Application 10.2.1 Middle East and Africa Standard Lancets Sales by Application (2017-2028) 10.2.2 Middle East and Africa Standard Lancets Revenue by Application (2017-2028) 10.3 Middle East and Africa Standard Lancets Market Size by Country 10.3.1 Middle East and Africa Standard Lancets Sales by Country (2017-2028) 10.3.2 Middle East and Africa Standard Lancets Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Roche 11.1.1 Roche Corporation Information 11.1.2 Roche Overview 11.1.3 Roche Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Roche Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Roche Recent Developments 11.2 Lifescan 11.2.1 Lifescan Corporation Information 11.2.2 Lifescan Overview 11.2.3 Lifescan Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Lifescan Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Lifescan Recent Developments 11.3 BD 11.3.1 BD Corporation Information 11.3.2 BD Overview 11.3.3 BD Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 BD Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 BD Recent Developments 11.4 Bayer 11.4.1 Bayer Corporation Information 11.4.2 Bayer Overview 11.4.3 Bayer Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Bayer Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Bayer Recent Developments 11.5 Abbott 11.5.1 Abbott Corporation Information 11.5.2 Abbott Overview 11.5.3 Abbott Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Abbott Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Abbott Recent Developments 11.6 B. Braun 11.6.1 B. Braun Corporation Information 11.6.2 B. Braun Overview 11.6.3 B. Braun Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 B. Braun Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 B. Braun Recent Developments 11.7 ARKRAY 11.7.1 ARKRAY Corporation Information 11.7.2 ARKRAY Overview 11.7.3 ARKRAY Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 ARKRAY Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 ARKRAY Recent Developments 11.8 Terumo 11.8.1 Terumo Corporation Information 11.8.2 Terumo Overview 11.8.3 Terumo Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Terumo Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Terumo Recent Developments 11.9 I-SENS 11.9.1 I-SENS Corporation Information 11.9.2 I-SENS Overview 11.9.3 I-SENS Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 I-SENS Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 I-SENS Recent Developments 11.10 Nipro 11.10.1 Nipro Corporation Information 11.10.2 Nipro Overview 11.10.3 Nipro Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Nipro Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Nipro Recent Developments 11.11 Omron 11.11.1 Omron Corporation Information 11.11.2 Omron Overview 11.11.3 Omron Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Omron Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Omron Recent Developments 11.12 Infopia 11.12.1 Infopia Corporation Information 11.12.2 Infopia Overview 11.12.3 Infopia Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 Infopia Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 Infopia Recent Developments 11.13 AgaMatrix 11.13.1 AgaMatrix Corporation Information 11.13.2 AgaMatrix Overview 11.13.3 AgaMatrix Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.13.4 AgaMatrix Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 AgaMatrix Recent Developments 11.14 Smiths Medical 11.14.1 Smiths Medical Corporation Information 11.14.2 Smiths Medical Overview 11.14.3 Smiths Medical Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.14.4 Smiths Medical Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.14.5 Smiths Medical Recent Developments 11.15 Sarstedt 11.15.1 Sarstedt Corporation Information 11.15.2 Sarstedt Overview 11.15.3 Sarstedt Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.15.4 Sarstedt Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.15.5 Sarstedt Recent Developments 11.16 SANNUO 11.16.1 SANNUO Corporation Information 11.16.2 SANNUO Overview 11.16.3 SANNUO Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.16.4 SANNUO Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.16.5 SANNUO Recent Developments 11.17 Yicheng 11.17.1 Yicheng Corporation Information 11.17.2 Yicheng Overview 11.17.3 Yicheng Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.17.4 Yicheng Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.17.5 Yicheng Recent Developments 11.18 Yuwell 11.18.1 Yuwell Corporation Information 11.18.2 Yuwell Overview 11.18.3 Yuwell Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.18.4 Yuwell Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.18.5 Yuwell Recent Developments 11.19 Greiner Bio One 11.19.1 Greiner Bio One Corporation Information 11.19.2 Greiner Bio One Overview 11.19.3 Greiner Bio One Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.19.4 Greiner Bio One Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.19.5 Greiner Bio One Recent Developments 11.20 Edan 11.20.1 Edan Corporation Information 11.20.2 Edan Overview 11.20.3 Edan Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.20.4 Edan Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.20.5 Edan Recent Developments 11.21 Narang Medical 11.21.1 Narang Medical Corporation Information 11.21.2 Narang Medical Overview 11.21.3 Narang Medical Standard Lancets Sales, Price, Revenue and Gross Margin (2017-2022) 11.21.4 Narang Medical Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications 11.21.5 Narang Medical Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Standard Lancets Industry Chain Analysis 12.2 Standard Lancets Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Standard Lancets Production Mode & Process 12.4 Standard Lancets Sales and Marketing 12.4.1 Standard Lancets Sales Channels 12.4.2 Standard Lancets Distributors 12.5 Standard Lancets Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Standard Lancets Industry Trends 13.2 Standard Lancets Market Drivers 13.3 Standard Lancets Market Challenges 13.4 Standard Lancets Market Restraints 14 Key Findings in The Global Standard Lancets Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
                
List of Tables Table 1. Global Standard Lancets Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Needle Table 3. Major Manufacturers of Blade Table 4. Global Standard Lancets Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 5. Global Standard Lancets Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Standard Lancets Sales by Region (2017-2022) & (K Units) Table 7. Global Standard Lancets Sales Market Share by Region (2017-2022) Table 8. Global Standard Lancets Sales by Region (2023-2028) & (K Units) Table 9. Global Standard Lancets Sales Market Share by Region (2023-2028) Table 10. Global Standard Lancets Revenue by Region (2017-2022) & (US$ Million) Table 11. Global Standard Lancets Revenue Market Share by Region (2017-2022) Table 12. Global Standard Lancets Revenue by Region (2023-2028) & (US$ Million) Table 13. Global Standard Lancets Revenue Market Share by Region (2023-2028) Table 14. Global Standard Lancets Sales by Manufacturers (2017-2022) & (K Units) Table 15. Global Standard Lancets Sales Share by Manufacturers (2017-2022) Table 16. Global Standard Lancets Revenue by Manufacturers (2017-2022) & (US$ Million) Table 17. Global Standard Lancets Revenue Share by Manufacturers (2017-2022) Table 18. Standard Lancets Price by Manufacturers (2017-2022) &(US$/Unit) Table 19. Global Standard Lancets Manufacturers Market Concentration Ratio (CR5 and HHI) Table 20. Global Standard Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Standard Lancets as of 2021) Table 21. Standard Lancets Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Standard Lancets Product Offered Table 23. Date of Manufacturers Enter into Standard Lancets Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Standard Lancets Sales by Type (2017-2022) & (K Units) Table 26. Global Standard Lancets Sales by Type (2023-2028) & (K Units) Table 27. Global Standard Lancets Sales Share by Type (2017-2022) Table 28. Global Standard Lancets Sales Share by Type (2023-2028) Table 29. Global Standard Lancets Revenue by Type (2017-2022) & (US$ Million) Table 30. Global Standard Lancets Revenue by Type (2023-2028) & (US$ Million) Table 31. Global Standard Lancets Revenue Share by Type (2017-2022) Table 32. Global Standard Lancets Revenue Share by Type (2023-2028) Table 33. Standard Lancets Price by Type (2017-2022) & (US$/Unit) Table 34. Global Standard Lancets Price Forecast by Type (2023-2028) & (US$/Unit) Table 35. Global Standard Lancets Sales by Application (2017-2022) & (K Units) Table 36. Global Standard Lancets Sales by Application (2023-2028) & (K Units) Table 37. Global Standard Lancets Sales Share by Application (2017-2022) Table 38. Global Standard Lancets Sales Share by Application (2023-2028) Table 39. Global Standard Lancets Revenue by Application (2017-2022) & (US$ Million) Table 40. Global Standard Lancets Revenue by Application (2023-2028) & (US$ Million) Table 41. Global Standard Lancets Revenue Share by Application (2017-2022) Table 42. Global Standard Lancets Revenue Share by Application (2023-2028) Table 43. Standard Lancets Price by Application (2017-2022) & (US$/Unit) Table 44. Global Standard Lancets Price Forecast by Application (2023-2028) & (US$/Unit) Table 45. North America Standard Lancets Sales by Type (2017-2022) & (K Units) Table 46. North America Standard Lancets Sales by Type (2023-2028) & (K Units) Table 47. North America Standard Lancets Revenue by Type (2017-2022) & (US$ Million) Table 48. North America Standard Lancets Revenue by Type (2023-2028) & (US$ Million) Table 49. North America Standard Lancets Sales by Application (2017-2022) & (K Units) Table 50. North America Standard Lancets Sales by Application (2023-2028) & (K Units) Table 51. North America Standard Lancets Revenue by Application (2017-2022) & (US$ Million) Table 52. North America Standard Lancets Revenue by Application (2023-2028) & (US$ Million) Table 53. North America Standard Lancets Sales by Country (2017-2022) & (K Units) Table 54. North America Standard Lancets Sales by Country (2023-2028) & (K Units) Table 55. North America Standard Lancets Revenue by Country (2017-2022) & (US$ Million) Table 56. North America Standard Lancets Revenue by Country (2023-2028) & (US$ Million) Table 57. Europe Standard Lancets Sales by Type (2017-2022) & (K Units) Table 58. Europe Standard Lancets Sales by Type (2023-2028) & (K Units) Table 59. Europe Standard Lancets Revenue by Type (2017-2022) & (US$ Million) Table 60. Europe Standard Lancets Revenue by Type (2023-2028) & (US$ Million) Table 61. Europe Standard Lancets Sales by Application (2017-2022) & (K Units) Table 62. Europe Standard Lancets Sales by Application (2023-2028) & (K Units) Table 63. Europe Standard Lancets Revenue by Application (2017-2022) & (US$ Million) Table 64. Europe Standard Lancets Revenue by Application (2023-2028) & (US$ Million) Table 65. Europe Standard Lancets Sales by Country (2017-2022) & (K Units) Table 66. Europe Standard Lancets Sales by Country (2023-2028) & (K Units) Table 67. Europe Standard Lancets Revenue by Country (2017-2022) & (US$ Million) Table 68. Europe Standard Lancets Revenue by Country (2023-2028) & (US$ Million) Table 69. Asia Pacific Standard Lancets Sales by Type (2017-2022) & (K Units) Table 70. Asia Pacific Standard Lancets Sales by Type (2023-2028) & (K Units) Table 71. Asia Pacific Standard Lancets Revenue by Type (2017-2022) & (US$ Million) Table 72. Asia Pacific Standard Lancets Revenue by Type (2023-2028) & (US$ Million) Table 73. Asia Pacific Standard Lancets Sales by Application (2017-2022) & (K Units) Table 74. Asia Pacific Standard Lancets Sales by Application (2023-2028) & (K Units) Table 75. Asia Pacific Standard Lancets Revenue by Application (2017-2022) & (US$ Million) Table 76. Asia Pacific Standard Lancets Revenue by Application (2023-2028) & (US$ Million) Table 77. Asia Pacific Standard Lancets Sales by Region (2017-2022) & (K Units) Table 78. Asia Pacific Standard Lancets Sales by Region (2023-2028) & (K Units) Table 79. Asia Pacific Standard Lancets Revenue by Region (2017-2022) & (US$ Million) Table 80. Asia Pacific Standard Lancets Revenue by Region (2023-2028) & (US$ Million) Table 81. Latin America Standard Lancets Sales by Type (2017-2022) & (K Units) Table 82. Latin America Standard Lancets Sales by Type (2023-2028) & (K Units) Table 83. Latin America Standard Lancets Revenue by Type (2017-2022) & (US$ Million) Table 84. Latin America Standard Lancets Revenue by Type (2023-2028) & (US$ Million) Table 85. Latin America Standard Lancets Sales by Application (2017-2022) & (K Units) Table 86. Latin America Standard Lancets Sales by Application (2023-2028) & (K Units) Table 87. Latin America Standard Lancets Revenue by Application (2017-2022) & (US$ Million) Table 88. Latin America Standard Lancets Revenue by Application (2023-2028) & (US$ Million) Table 89. Latin America Standard Lancets Sales by Country (2017-2022) & (K Units) Table 90. Latin America Standard Lancets Sales by Country (2023-2028) & (K Units) Table 91. Latin America Standard Lancets Revenue by Country (2017-2022) & (US$ Million) Table 92. Latin America Standard Lancets Revenue by Country (2023-2028) & (US$ Million) Table 93. Middle East and Africa Standard Lancets Sales by Type (2017-2022) & (K Units) Table 94. Middle East and Africa Standard Lancets Sales by Type (2023-2028) & (K Units) Table 95. Middle East and Africa Standard Lancets Revenue by Type (2017-2022) & (US$ Million) Table 96. Middle East and Africa Standard Lancets Revenue by Type (2023-2028) & (US$ Million) Table 97. Middle East and Africa Standard Lancets Sales by Application (2017-2022) & (K Units) Table 98. Middle East and Africa Standard Lancets Sales by Application (2023-2028) & (K Units) Table 99. Middle East and Africa Standard Lancets Revenue by Application (2017-2022) & (US$ Million) Table 100. Middle East and Africa Standard Lancets Revenue by Application (2023-2028) & (US$ Million) Table 101. Middle East and Africa Standard Lancets Sales by Country (2017-2022) & (K Units) Table 102. Middle East and Africa Standard Lancets Sales by Country (2023-2028) & (K Units) Table 103. Middle East and Africa Standard Lancets Revenue by Country (2017-2022) & (US$ Million) Table 104. Middle East and Africa Standard Lancets Revenue by Country (2023-2028) & (US$ Million) Table 105. Roche Corporation Information Table 106. Roche Description and Major Businesses Table 107. Roche Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 108. Roche Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 109. Roche Recent Developments Table 110. Lifescan Corporation Information Table 111. Lifescan Description and Major Businesses Table 112. Lifescan Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 113. Lifescan Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 114. Lifescan Recent Developments Table 115. BD Corporation Information Table 116. BD Description and Major Businesses Table 117. BD Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 118. BD Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 119. BD Recent Developments Table 120. Bayer Corporation Information Table 121. Bayer Description and Major Businesses Table 122. Bayer Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 123. Bayer Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 124. Bayer Recent Developments Table 125. Abbott Corporation Information Table 126. Abbott Description and Major Businesses Table 127. Abbott Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 128. Abbott Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 129. Abbott Recent Developments Table 130. B. Braun Corporation Information Table 131. B. Braun Description and Major Businesses Table 132. B. Braun Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 133. B. Braun Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 134. B. Braun Recent Developments Table 135. ARKRAY Corporation Information Table 136. ARKRAY Description and Major Businesses Table 137. ARKRAY Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 138. ARKRAY Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 139. ARKRAY Recent Developments Table 140. Terumo Corporation Information Table 141. Terumo Description and Major Businesses Table 142. Terumo Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 143. Terumo Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 144. Terumo Recent Developments Table 145. I-SENS Corporation Information Table 146. I-SENS Description and Major Businesses Table 147. I-SENS Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 148. I-SENS Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 149. I-SENS Recent Developments Table 150. Nipro Corporation Information Table 151. Nipro Description and Major Businesses Table 152. Nipro Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 153. Nipro Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 154. Nipro Recent Developments Table 155. Omron Corporation Information Table 156. Omron Description and Major Businesses Table 157. Omron Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 158. Omron Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 159. Omron Recent Developments Table 160. Infopia Corporation Information Table 161. Infopia Description and Major Businesses Table 162. Infopia Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 163. Infopia Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 164. Infopia Recent Developments Table 165. AgaMatrix Corporation Information Table 166. AgaMatrix Description and Major Businesses Table 167. AgaMatrix Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 168. AgaMatrix Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 169. AgaMatrix Recent Developments Table 170. Smiths Medical Corporation Information Table 171. Smiths Medical Description and Major Businesses Table 172. Smiths Medical Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 173. Smiths Medical Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 174. Smiths Medical Recent Developments Table 175. Sarstedt Corporation Information Table 176. Sarstedt Description and Major Businesses Table 177. Sarstedt Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 178. Sarstedt Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 179. Sarstedt Recent Developments Table 180. SANNUO Corporation Information Table 181. SANNUO Description and Major Businesses Table 182. SANNUO Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 183. SANNUO Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 184. SANNUO Recent Developments Table 185. Yicheng Corporation Information Table 186. Yicheng Description and Major Businesses Table 187. Yicheng Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 188. Yicheng Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 189. Yicheng Recent Developments Table 190. Yuwell Corporation Information Table 191. Yuwell Description and Major Businesses Table 192. Yuwell Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 193. Yuwell Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 194. Yuwell Recent Developments Table 195. Greiner Bio One Corporation Information Table 196. Greiner Bio One Description and Major Businesses Table 197. Greiner Bio One Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 198. Greiner Bio One Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 199. Greiner Bio One Recent Developments Table 200. Edan Corporation Information Table 201. Edan Description and Major Businesses Table 202. Edan Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 203. Edan Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 204. Edan Recent Developments Table 205. Narang Medical Corporation Information Table 206. Narang Medical Description and Major Businesses Table 207. Narang Medical Standard Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 208. Narang Medical Standard Lancets Product Model Numbers, Pictures, Descriptions and Specifications Table 209. Narang Medical Recent Developments Table 210. Key Raw Materials Lists Table 211. Raw Materials Key Suppliers Lists Table 212. Standard Lancets Distributors List Table 213. Standard Lancets Customers List Table 214. Standard Lancets Market Trends Table 215. Standard Lancets Market Drivers Table 216. Standard Lancets Market Challenges Table 217. Standard Lancets Market Restraints Table 218. Research Programs/Design for This Report Table 219. Key Data Information from Secondary Sources Table 220. Key Data Information from Primary Sources List of Figures Figure 1. Standard Lancets Product Picture Figure 3. Global Standard Lancets Market Share by Type in 2021 & 2028 Figure 3. Needle Product Picture Figure 4. Blade Product Picture Figure 5. Global Standard Lancets Market Share by Application in 2021 & 2028 Figure 6. Hospitals and Clinics Figure 7. Homecare Settings Figure 8. Others Figure 9. Standard Lancets Report Years Considered Figure 10. Global Standard Lancets Sales 2017-2028 (K Units) Figure 11. Global Standard Lancets Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Standard Lancets Revenue 2017-2028 (US$ Million) Figure 13. Global Standard Lancets Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 14. Global Standard Lancets Sales Market Share by Region (2017-2022) Figure 15. Global Standard Lancets Sales Market Share by Region (2023-2028) Figure 16. North America Standard Lancets Sales YoY (2017-2028) & (K Units) Figure 17. North America Standard Lancets Revenue YoY (2017-2028) & (US$ Million) Figure 18. Europe Standard Lancets Sales YoY (2017-2028) & (K Units) Figure 19. Europe Standard Lancets Revenue YoY (2017-2028) & (US$ Million) Figure 20. Asia-Pacific Standard Lancets Sales YoY (2017-2028) & (K Units) Figure 21. Asia-Pacific Standard Lancets Revenue YoY (2017-2028) & (US$ Million) Figure 22. Latin America Standard Lancets Sales YoY (2017-2028) & (K Units) Figure 23. Latin America Standard Lancets Revenue YoY (2017-2028) & (US$ Million) Figure 24. Middle East & Africa Standard Lancets Sales YoY (2017-2028) & (K Units) Figure 25. Middle East & Africa Standard Lancets Revenue YoY (2017-2028) & (US$ Million) Figure 26. The Standard Lancets Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 27. The Top 5 and 10 Largest Manufacturers of Standard Lancets in the World: Market Share by Standard Lancets Revenue in 2021 Figure 28. Global Standard Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 29. Global Standard Lancets Sales Market Share by Type (2017-2028) Figure 30. Global Standard Lancets Revenue Market Share by Type (2017-2028) Figure 31. Global Standard Lancets Sales Market Share by Application (2017-2028) Figure 32. Global Standard Lancets Revenue Market Share by Application (2017-2028) Figure 33. North America Standard Lancets Sales Market Share by Type (2017-2028) Figure 34. North America Standard Lancets Revenue Market Share by Type (2017-2028) Figure 35. North America Standard Lancets Sales Market Share by Application (2017-2028) Figure 36. North America Standard Lancets Revenue Market Share by Application (2017-2028) Figure 37. North America Standard Lancets Sales Share by Country (2017-2028) Figure 38. North America Standard Lancets Revenue Share by Country (2017-2028) Figure 39. U.S. Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 40. Canada Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 41. Europe Standard Lancets Sales Market Share by Type (2017-2028) Figure 42. Europe Standard Lancets Revenue Market Share by Type (2017-2028) Figure 43. Europe Standard Lancets Sales Market Share by Application (2017-2028) Figure 44. Europe Standard Lancets Revenue Market Share by Application (2017-2028) Figure 45. Europe Standard Lancets Sales Share by Country (2017-2028) Figure 46. Europe Standard Lancets Revenue Share by Country (2017-2028) Figure 47. Germany Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 48. France Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 49. U.K. Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 50. Italy Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 51. Russia Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 52. Asia Pacific Standard Lancets Sales Market Share by Type (2017-2028) Figure 53. Asia Pacific Standard Lancets Revenue Market Share by Type (2017-2028) Figure 54. Asia Pacific Standard Lancets Sales Market Share by Application (2017-2028) Figure 55. Asia Pacific Standard Lancets Revenue Market Share by Application (2017-2028) Figure 56. Asia Pacific Standard Lancets Sales Share by Region (2017-2028) Figure 57. Asia Pacific Standard Lancets Revenue Share by Region (2017-2028) Figure 58. China Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 59. Japan Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 60. South Korea Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 61. India Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 62. Australia Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 63. Taiwan Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 64. Indonesia Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 65. Thailand Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 66. Malaysia Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 67. Philippines Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 68. Latin America Standard Lancets Sales Market Share by Type (2017-2028) Figure 69. Latin America Standard Lancets Revenue Market Share by Type (2017-2028) Figure 70. Latin America Standard Lancets Sales Market Share by Application (2017-2028) Figure 71. Latin America Standard Lancets Revenue Market Share by Application (2017-2028) Figure 72. Latin America Standard Lancets Sales Share by Country (2017-2028) Figure 73. Latin America Standard Lancets Revenue Share by Country (2017-2028) Figure 74. Mexico Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 75. Brazil Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 76. Argentina Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 77. Middle East and Africa Standard Lancets Sales Market Share by Type (2017-2028) Figure 78. Middle East and Africa Standard Lancets Revenue Market Share by Type (2017-2028) Figure 79. Middle East and Africa Standard Lancets Sales Market Share by Application (2017-2028) Figure 80. Middle East and Africa Standard Lancets Revenue Market Share by Application (2017-2028) Figure 81. Middle East and Africa Standard Lancets Sales Share by Country (2017-2028) Figure 82. Middle East and Africa Standard Lancets Revenue Share by Country (2017-2028) Figure 83. Turkey Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 84. Saudi Arabia Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 85. UAE Standard Lancets Revenue (2017-2028) & (US$ Million) Figure 86. Standard Lancets Value Chain Figure 87. Standard Lancets Production Process Figure 88. Channels of Distribution Figure 89. Distributors Profiles Figure 90. Bottom-up and Top-down Approaches for This Report Figure 91. Data Triangulation Figure 92. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.